Samsara BioCapital, L.P. has an estimated net worth of $582 Million. This is based on reported shares across multiple companies, which include CARGO Therapeutics, Inc., Mineralys Therapeutics, Inc., Graphite Bio, Inc., Neurogene Inc., Kalaris Therapeutics, Inc., Scholar Rock Holding Corp, and vTv Therapeutics Inc..

2021 was Samsara BioCapital, L.P.'s most active year for acquiring shares with 13 total transactions. Samsara BioCapital, L.P.'s most active month to acquire stocks was the month of September. 2023 was Samsara BioCapital, L.P.'s most active year for disposing of shares, totalling 5 transactions. Samsara BioCapital, L.P.'s most active month to dispose stocks was the month of May. 2023 saw Samsara BioCapital, L.P. paying a total of $39,999,989.85 for 10,801,131 shares, this is the most they've acquired in one year. In 2021 Samsara BioCapital, L.P. cashed out on 16,857,708 shares for a total of $0.00, their largest year based on trade value.